X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development FDA Approvals

Vault Health Delivers Access to the First FDA EUA Approved At-Home Saliva Test for COVID-19

Content Team by Content Team
11th May 2020
in FDA Approvals, Press Statements
Vault Health Delivers Access to the First FDA EUA Approved At-Home Saliva Test for COVID-19

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Vault Health, a startup specializing in healthcare for men, has turned focus to help fulfill demand for hard to get COVID-19 tests nationwide. Beginning today, Vault will make thousands of tests available every week and will continue to scale test availability as capacity of RUCDR Infinite Biologics quickly expands.

“We felt an obligation as a team to help expand COVID-19 testing across America and help the country open for business. Using our technology and healthcare platform, we are working with RUCDR Infinite Biologics to make their saliva test available to the public and businesses across the nation. This is the first and only saliva test approved by the FDA for at-home testing. With our team of practitioners, we have capacity to manage 10,000 tests per day and are building to scale. People experiencing COVID-like symptoms need to know if they can safely return to work. We will help them find the answer fast,” said Jason Feldman, CEO, Vault Health.

The medically supervised saliva collection test for COVID-19 is more sensitive and safer than the existing swab test, and is performed under the supervision of a Vault healthcare provider through a video telehealth visit, eliminating the risk of person-to-person exposure to the virus. This test is precise in detecting the presence of three genes that are found in the SARS-CoV-2 virus, which causes COVID-19, using a technique called qPCR. Vault Health will be following state and federal reporting guidelines to provide requisite patient infection data to help health authorities as they continue to respond to this unprecedented pandemic.

“We implemented and are supporting this test for three reasons. Beyond the rapid, accurate and broad testing for COVID-19 that is critically necessary, this test has other crucial benefits: it expands the availability of testing across the U.S., decreases the risk to medical professionals who are currently directly exposed to the virus when performing a nasal swab-based sample collection, and preserves precious personal protective equipment (PPE) which is in limited supply. We are excited Vault Health moved so fast to deliver this solution,” said Dr. Andrew Brooks, COO and Director of Technology Development, RUCDR Infinite Biologics.

Vault Health streamlines the process for prescribing, supervising and reporting results for the test:

  • Complete an online form with personal information and questions about exposure to SARS-CoV-2 and COVID-19 symptoms (must be at least 18 years old)
  • Receive test kit via UPS overnight shipping
  • Open box and follow instructions for a Zoom video conference for supervised saliva collection with a Vault healthcare provider
  • The Vault medical professional walks through the process on how to provide the saliva sample and provides instructions on how to return the kit to the lab for testing
  • Ship back to lab in the provided pre-addressed UPS overnight clinical sample pouch
  • Upon receipt at RUCDR’s New Jersey facility, the sample will be processed and lab results will be available within 48-72 hours

U.S. residents that are 18 years or older can visit www.vaulthealth.com/COVID and order a lab test for $150, which covers the cost for telemedicine, operations, overnight shipping, the test kit and lab processing, with no profit to Vault Health.

About Vault
Vault is a performace healthcare service designed to help men take control of their health through specialized in-home treatments for a better body, better sex and better brain health. Through extensive education, professional medical evaluation, and personalized treatment, Vault overcomes shortcomings in existing men’s healthcare offerings to help more men achieve optimal overall health.

Previous Post

United Imaging delivered twelve mobile DR systems to support Ukraine in fight against COVID-19

Next Post

Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
Breast Cancer Therapy
Clinical Trials

US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

27th September 2025
Cerebral Folate Deficiency
Drug Development

US FDA to Approve Leucovorin for Cerebral Folate Deficiency

25th September 2025
Pediatric Eczema
Drug Development

FDA Grant Approval for Opzelura Cream for Pediatric Eczema

20th September 2025
Next Post
Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project

Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In